Veterans Medical Research Foundation   Report issue

Foundation Phase 1 Phase 2 Phase 4
Founded: San Diego CA United States (1989)

Organization Overview

First Clinical Trial
2001
NCT00047450
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Robert R. Henry, MD | Veterans Medical Research Foundation

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Alzheimer Disease (Phase 4)

Bipolar Disorder (Phase 4)

Disease (Phase 4)

Glucose Intolerance (Phase 1)

Hepatitis C (Phase 2)

Hyperglycemia (Phase 2)

Inflammation (Phase 2)

Insulin Resistance (Phase 4)

Kidney Diseases (Phase 2)

Liver Diseases (Phase 2)

Lung Diseases (Phase 2)

Lung Diseases, Obstructive (Phase 2)

Metabolic Syndrome (Phase 4)

Prediabetic State (Phase 1)

Psychotic Disorders (Phase 4)

Pulmonary Disease, Chronic Obstructive (Phase 2)

Renal Insufficiency, Chronic (Phase 2)

Schizophrenia (Phase 4)

Syndrome (Phase 4)

Tobacco Use Disorder (Phase 4)

Vitamin D Deficiency (Phase 2)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 15
  • # of Trial APIs: 13